An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how ...

Our NAV-005 antagonist binds the immunosuppressive HIO-1 factor and blocks its ability to suppress mAb, TCE and ADC ...

A new HIC–MS method using ammonium tartrate improves ADC characterization, enabling efficient drug-to-antibody ratio analysis without complex workflows. A proteomics workflow combining laser ablation ...

Cleveland Clinic researchers have found that nearly two-thirds of patients with HER2-positive metastatic breast cancer did not receive the guideline-recommended standard of care treatment between 2015 ...

As monkey prices peaked in 2022, Joinn spent about 1.8 billion yuan to acquire two laboratory monkey companies and built its ...

Antibody-Drug Conjugates (ADCs) represent a revolutionary approach in cancer treatment by combining the selectivity of monoclonal antibodies with the potency of cytotoxic drugs. However, the unique ...

COLORADO SPRINGS, CO, UNITED STATES, January 14, 2026 /EINPresswire.com/ -- Lahjavida Bio, a biotechnology company ...

OS Animal Health (OSAH), a wholly owned OS Therapies (OSTX) subsidiary, targets an IPO on NYSE American or Nasdaq ...

Akeso, Inc. (9926.HK) is pleased to share that the international industry media FirstWord Pharma released its list titled ...

Recent clinical developments in the treatment of platinum-resistant ovarian cancer (PROC) have introduced several novel therapeutic classes, including selective glucocorticoid receptor antagonists, ...

Shortly after acquiring Elektrofi to beef up its subcutaneous drug-delivery offerings, Halozyme Therapeutics has struck ...

Licensing, funding, and IPO activity support sector development South Korea's biopharma companies have secured about $4.2b in ...